作者|黄绎达编辑|张帆封面来源|视觉中国11月10日,礼来与英硅智能达成一项战略合作,依托英硅智能自主研发的AI制药平台Pharma.AI之相关技术能力,结合礼来在药物开发与疾病研究领域的长期积淀,双方将在创新疗法方面展开合作。据报道,在该项合作中,英硅智能可获得的总收益高达1亿美元。在此之前,英伟达和制药巨头礼来于今年10月的NVIDIA GTC大会上宣布合作构建制药行业“最强大”的AI...
Source Link作者|黄绎达编辑|张帆封面来源|视觉中国11月10日,礼来与英硅智能达成一项战略合作,依托英硅智能自主研发的AI制药平台Pharma.AI之相关技术能力,结合礼来在药物开发与疾病研究领域的长期积淀,双方将在创新疗法方面展开合作。据报道,在该项合作中,英硅智能可获得的总收益高达1亿美元。在此之前,英伟达和制药巨头礼来于今年10月的NVIDIA GTC大会上宣布合作构建制药行业“最强大”的AI...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.